Cargando…
Zielgerichtete Therapie beim metastasierten Mammakarzinom – welche molekularen Tests sind notwendig?
In recent years, targeted therapy for breast cancer has received increasingly more attention. In addition to hormone receptors and human epidermal growth factor 2 (HER2), the immunohistochemical detection of programmed cell death ligand 1 (PD-L1) in advanced triple-negative breast cancer and the det...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264922/ https://www.ncbi.nlm.nih.gov/pubmed/32837693 http://dx.doi.org/10.1007/s41974-020-00141-z |